A Study of Elotuzumab in Combination With Pomalidomide and Low Dose Dexamethasone and Elotuzumab in Combination With Nivolumab in Patients With Multiple Myeloma Relapsed or Refractory to Prior Treatment With Lenalidomide.

Mount Sinai Medical Center, New York

Virginia Cancer Specialists (Leesburg) - USOR, Leesburg

American Oncology Partners of Maryland, PA, Bethesda

Bay Hematology Oncology, Easton

Greenville Health System, Greenville

Florida Cancer Specialists - EAST - SCRI - PPDS, St. Petersburg

Florida Cancer Specialists - NORTH - SCRI - PPDS, St. Petersburg

Southern Cancer Center, Mobile

Tennessee Oncology NASH - SCRI - PPDS, Nashville

Jones Clinic PC, Germantown

University of Michigan, Ann Arbor

Barbara Ann Karmanos Cancer Center, Detroit

Aurora Health Care, Burlington

Avera Health Care, Sioux Falls

Illinois Cancer Care, Peoria

Washington University, St Louis

Texas Oncology (Loop) - USOR, San Antonio

Colorado Blood Cancer Institute - PPDS, Denver

Rocky Mountain Cancer Centers (Williams) - USOR, Denver

Sansum Clinic - USOR, Santa Barbara

Swedish Medical Center, Seattle

Cancer Care Northwest, Spokane Valley